# Sana Biotechnology, Inc.: filings

SANA · Nasdaq · CIK 1770121 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sana.md) · [Financials](/companies/sana/financials.md) · [Filings](/companies/sana/filings.md) · [Insiders](/companies/sana/insiders.md)

## Reports and events: 99 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 146, 8-K 67, 3 26, 4/A 19, 10-Q 17, SC 13G/A 15, 144 13, S-8 7, SC 13G 7, 10-K 6, 424B5 6, CORRESP 5, DEF 14A 5, DEFA14A 5, UPLOAD 5, ARS 4, EFFECT 3, S-1/A 3, S-3ASR 3, SCHEDULE 13G/A 3, 3/A 2, D 2, POS AM 2, POSASR 2, 144/A 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, POS EX 1, S-1 1, S-1MEF 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 12:00 ET | [8-K](/filings/0001193125-26-384405.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-384405 |
| 2026-08-10 | 20:11 ET | [10-Q](/filings/0001193125-26-342395.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342395 |
| 2026-08-10 | 20:09 ET | [8-K](/filings/0001193125-26-342371.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342371 |
| 2026-06-05 | 20:05 ET | [8-K](/filings/0001193125-26-259532.md) | 5.07 Shareholder vote results | 0001193125-26-259532 |
| 2026-05-15 | 20:06 ET | [8-K](/filings/0001193125-26-226674.md) | 8.01 Other events | 0001193125-26-226674 |
| 2026-05-11 | 20:10 ET | [10-Q](/filings/0001193125-26-216769.md) | Quarterly report, period 2026-03-31 | 0001193125-26-216769 |
| 2026-05-11 | 20:08 ET | [8-K](/filings/0001193125-26-216758.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216758 |
| 2026-04-24 | 10:20 ET | [DEF 14A](/filings/0001193125-26-174883.md) | Proxy statement, period 2026-06-04 | 0001193125-26-174883 |
| 2026-04-24 | 10:00 ET | [8-K](/filings/0001193125-26-174531.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-174531 |
| 2026-04-13 | 20:10 ET | [8-K](/filings/0001193125-26-152868.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-152868 |
| 2026-03-03 | 21:14 ET | [10-K](/filings/0001193125-26-088215.md) | Annual report, period 2025-12-31 | 0001193125-26-088215 |
| 2026-03-03 | 21:11 ET | [8-K](/filings/0001193125-26-088203.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-088203 |
| 2026-02-17 | 14:07 ET | [8-K](/filings/0001193125-26-053294.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-053294 |
| 2026-01-14 | 17:45 ET | [8-K](/filings/0001193125-26-012664.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-012664 |
| 2025-11-06 | 21:15 ET | [10-Q](/filings/0001193125-25-269569.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269569 |
| 2025-11-06 | 21:10 ET | [8-K](/filings/0001193125-25-269522.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269522 |
| 2025-09-05 | 10:00 ET | [8-K](/filings/0001193125-25-196414.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-25-196414 |
| 2025-08-29 | 20:11 ET | [8-K](/filings/0001193125-25-192766.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-192766 |
| 2025-08-11 | 20:10 ET | [10-Q](/filings/0001770121-25-000010.md) | Quarterly report, period 2025-06-30 | 0001770121-25-000010 |
| 2025-08-11 | 20:08 ET | [8-K](/filings/0001770121-25-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770121-25-000009 |
| 2025-08-07 | 21:11 ET | [8-K](/filings/0001193125-25-175571.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-175571 |
| 2025-08-06 | 20:31 ET | [8-K](/filings/0001193125-25-174506.md) | 2.02 Results of operations; 8.01 Other events | 0001193125-25-174506 |
| 2025-06-23 | 14:10 ET | [8-K](/filings/0000950170-25-088752.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-088752 |
| 2025-06-06 | 20:05 ET | [8-K](/filings/0000950170-25-083044.md) | 5.07 Shareholder vote results | 0000950170-25-083044 |
| 2025-05-08 | 20:10 ET | [10-Q](/filings/0000950170-25-066943.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066943 |
| 2025-05-08 | 20:08 ET | [8-K](/filings/0000950170-25-066933.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-066933 |
| 2025-04-25 | 10:08 ET | [DEF 14A](/filings/0001193125-25-094656.md) | Proxy statement, period 2025-06-05 | 0001193125-25-094656 |
| 2025-03-17 | 20:12 ET | [10-K](/filings/0000950170-25-040254.md) | Annual report, period 2024-12-31 | 0000950170-25-040254 |
| 2025-03-17 | 20:08 ET | [8-K](/filings/0000950170-25-040241.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-040241 |
| 2025-01-13 | 14:00 ET | [8-K](/filings/0001193125-25-005047.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005047 |
| 2024-11-08 | 14:14 ET | [10-Q](/filings/0000950170-24-123730.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123730 |
| 2024-11-08 | 14:07 ET | [8-K](/filings/0000950170-24-123727.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123727 |
| 2024-10-08 | 20:05 ET | [8-K](/filings/0000950170-24-113524.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-113524 |
| 2024-09-12 | 20:36 ET | [8-K](/filings/0001193125-24-218049.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-218049 |
| 2024-08-08 | 20:21 ET | [10-Q](/filings/0000950170-24-094052.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094052 |
| 2024-08-08 | 20:12 ET | [8-K](/filings/0000950170-24-093976.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093976 |
| 2024-06-07 | 20:05 ET | [8-K](/filings/0000950170-24-070603.md) | 5.07 Shareholder vote results | 0000950170-24-070603 |
| 2024-05-08 | 20:21 ET | [10-Q](/filings/0000950170-24-055727.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055727 |
| 2024-05-08 | 20:13 ET | [8-K](/filings/0000950170-24-055673.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055673 |
| 2024-04-26 | 10:11 ET | [DEF 14A](/filings/0001193125-24-115454.md) | Proxy statement, period 2024-06-06 | 0001193125-24-115454 |
| 2024-04-18 | 21:01 ET | [8-K](/filings/0001193125-24-100902.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-100902 |
| 2024-02-29 | 21:20 ET | [10-K](/filings/0000950170-24-023119.md) | Annual report, period 2023-12-31 | 0000950170-24-023119 |
| 2024-02-29 | 21:12 ET | [8-K](/filings/0000950170-24-023083.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-023083 |
| 2024-02-08 | 22:20 ET | [8-K](/filings/0001193125-24-028506.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-028506 |
| 2024-02-07 | 21:12 ET | [8-K](/filings/0001193125-24-026692.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-026692 |
| 2024-01-09 | 14:00 ET | [8-K](/filings/0001193125-24-004910.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-004910 |
| 2023-12-11 | 21:01 ET | [8-K](/filings/0001193125-23-292542.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-292542 |
| 2023-11-08 | 21:24 ET | [10-Q](/filings/0000950170-23-061171.md) | Quarterly report, period 2023-09-30 | 0000950170-23-061171 |
| 2023-11-08 | 21:14 ET | [8-K](/filings/0000950170-23-061130.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-061130 |
| 2023-10-10 | 20:21 ET | [8-K](/filings/0001193125-23-253493.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-253493 |

Page 1 of 2. [Older](/companies/sana/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.